SUNNYVALE, Calif., April 13,
2023 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) will report financial results for
the third quarter of fiscal year 2023, ended March 31, 2023, during a conference call hosted
by company management at 1:30 p.m.
PT/4:30 p.m. ET on
April 26, 2023.
The conference call dial-in numbers are (833) 316-0563
(USA) or (412) 317-5747
(international). In addition, a dial-up replay of the conference
call will be available approximately one hour after the call's
conclusion for one week. The replay number is (877) 344-7529
(USA) or (412) 317-0088
(international), conference ID: 3072079.
A live webcast of the call will also be available from the
Investor Relations section of the company's website at
investors.accuray.com. A webcast replay can be accessed on the
website and will remain available until Accuray announces its
results for the fourth quarter of fiscal 2023.
About Accuray
Accuray Incorporated (Nasdaq: ARAY) is committed to expanding
the powerful potential of radiation therapy to improve as many
lives as possible. We invent unique, market-changing solutions that
are designed to deliver radiation treatments for even the most
complex cases—while making commonly treatable cases even easier—to
meet the full spectrum of patient needs. We are dedicated to
continuous innovation in radiation therapy for oncology,
neuro-radiosurgery, and beyond, as we partner with clinicians and
administrators, empowering them to help patients get back to their
lives, faster. Accuray is headquartered
in Sunnyvale, California, with facilities worldwide. To
learn more, visit www.accuray.com or follow us
on Facebook, LinkedIn, Twitter,
and YouTube.
Investor Contact
Aman Patel, CFA
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
aman.patel@westwicke.com
Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2023-financial-results-on-april-26-2023-301797121.html
SOURCE Accuray Incorporated